Core Scientific (CORZ) Gains from Investment Securities (2021 - 2026)

Core Scientific has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $1.1 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1.1 million, up 18350.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 1281.56% YoY), and the FY2024 annual result was $3.4 million, down 7.24% from the prior year.
• Gains from Investment Securities came in at $1.1 million for Q1 2026 at Core Scientific, up from -$300000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q1 2026 to a low of -$31.6 million in Q4 2022.
• The 5-year median for Gains from Investment Securities is -$300000.0 (2025), against an average of -$4.1 million.
• Across the five-year window, Gains from Investment Securities slumped 1654.48% in 2025 and jumped 18350.0% in 2026, its largest moves.
• Core Scientific's Gains from Investment Securities stood at -$31.6 million in 2022, then soared by 100.78% to $247000.0 in 2023, then tumbled by 98.79% to $3000.0 in 2024, then plunged by 10100.0% to -$300000.0 in 2025, then jumped by 465.0% to $1.1 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.1 million (Q1 2026), -$300000.0 (Q3 2025), and -$4.2 million (Q2 2025), per Business Quant data.